- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07526220
Fatores Prognósticos em Doentes Críticos Internados após Ingestão de Substâncias Cáusticas em França (DATACAUSTIC)
Fatores Prognósticos em Doentes Críticos Admitidos Após Ingestão de Cáusticos em França: um Estudo Retrospetivo Multicêntrico Nacional
DATACAUSTIC is a national retrospective multicentre observational study designed to identify prognostic factors associated with outcomes in critically ill adult patients admitted after caustic ingestion in France.
Visão geral do estudo
Descrição detalhada
Introduction Caustic ingestion in adults is a rare but increasingly frequent medical emergency associated with substantial early morbidity and mortality. Among the most severe cases requiring admission to critical care, short-term mortality is high, and long-term outcomes remain insufficiently characterised. Because individual centres manage only a limited number of such patients, the prognostic factors associated with 1-year mortality, medical and surgical complications, and long-term reconstruction are still poorly defined. The DATACAUSTIC study aims to address this knowledge gap through a national multicentre retrospective analysis of critically ill adult patients admitted after caustic ingestion in France.
Methods DATACAUSTIC is a national, retrospective, multicentre observational study conducted in major French referral centres managing severe caustic ingestions. Adult patients aged 18 years or older admitted to a critical care setting within 72 hours after caustic ingestion between January 2014 and December 2024 will be eligible. Data will be extracted from electronic medical records, hospital discharge reports, and ancillary investigation software. Collected variables will include baseline characteristics, type and estimated quantity of caustic agent, intentionality, co-intoxications, timing of initial management, imaging and endoscopic findings, need for surgery, organ support requirements, biological data from admission to day 7, and in-hospital complications. The primary outcome is 1-year mortality. Secondary outcomes include ICU and hospital mortality, day-28 mortality, infectious, medical and surgical complications, organ failure, tracheotomy, length of stay, oesophageal stenosis, and reconstructive surgery within 1 year. Statistical analyses will include univariable and multivariable regression models, with mixed-effects models used when appropriate to account for repeated measurements and centre-related variability.
Expected Results The study is expected to provide a comprehensive description of the epidemiology, management pathways, and outcomes of critically ill patients with severe caustic ingestion in France. It should identify clinical, radiological, surgical, and biological factors associated with 1-year mortality and other major adverse outcomes. In particular, DATACAUSTIC is expected to improve understanding of early severity markers, the prognostic value of organ failures and supportive therapies, and the burden of long-term digestive and reconstructive sequelae in survivors.
Perspective By generating robust multicentre data in a rare but highly severe condition, DATACAUSTIC may help refine risk stratification, optimise critical care and surgical decision-making, and improve patient pathways from acute management to long-term follow-up. The findings could support future national recommendations, guide the design of prospective studies, and contribute to more standardised management strategies for severe caustic ingestion in critical care.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Benjamin Deniau, MD
- Número de telefone: 0142494949
- E-mail: benjdeniau@gmail.com
Locais de estudo
-
-
-
Paris, França, 75010
- Recrutamento
- Hopital Saint louis
-
Contato:
- BENJAMIN DENIAU, MD
- E-mail: benjdeniau@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Adult patients admitted in ICU after caustic ingestion in France
Descrição
Inclusion Criteria:
- age 18 years or older;
- admission to a critical care unit for caustic ingestion within 72 hours;
- no opposition to participation/data collection
Exclusion Criteria:
- Refus de participer à la recherche
- Ingestion de caustique ne nécessitant pas une prise en charge en soins critiques
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: COHORT
- Perspectivas de Tempo: RETROSPECTIVE
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
observationnal / patients admitted after caustic ingestion in France
Patients admitted after caustic ingestion in France |
No intervention / data collection only |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
1-year mortality
Prazo: 1 year
|
All-cause mortality at 1 year after admission to critical care for caustic ingestion |
1 year
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Complications and clinical course - mortality during hospital/ICU stay
Prazo: 1 year
|
ICU and hospital mortality |
1 year
|
|
Complications and clinical course - mortality at d28
Prazo: day-28
|
day-28 mortality |
day-28
|
|
Complications
Prazo: 1 year
|
Surgical and medical complications |
1 year
|
|
Complications and clinical course - organ support
Prazo: 1 year
|
Organ support |
1 year
|
|
Complications and clinical course - duration of stay
Prazo: 1 year
|
Length of stay |
1 year
|
|
Complications and clinical course
Prazo: 1 year
|
Late complications/reconstructive surgery |
1 year
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Benjamin Deniau, MD, Hopital Saint Louis - Paris
Publicações e links úteis
Publicações Gerais
- Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002. No abstract available.
- Chirica M, Bonavina L, Kelly MD, Sarfati E, Cattan P. Caustic ingestion. Lancet. 2017 May 20;389(10083):2041-2052. doi: 10.1016/S0140-6736(16)30313-0. Epub 2016 Oct 26.
- Deniau B, Boulet N, Petrier M, Mezzarobba M, Coutrot M, Cattan P, Corte H, Depret F, Lefrant JY, Plaud B, Boudemaghe T. Epidemiologic features and outcomes associated with caustic ingestion among adults admitted in intensive care unit from 2013 to 2019: a French national observational study. Eur J Trauma Emerg Surg. 2024 Jun;50(3):905-912. doi: 10.1007/s00068-023-02392-9. Epub 2023 Dec 20.
- Challine A, Maggiori L, Katsahian S, Corte H, Goere D, Lazzati A, Cattan P, Chirica M. Outcomes Associated With Caustic Ingestion Among Adults in a National Prospective Database in France. JAMA Surg. 2022 Feb 1;157(2):112-119. doi: 10.1001/jamasurg.2021.6368.
- Hoffman RS, Burns MM, Gosselin S. Ingestion of Caustic Substances. N Engl J Med. 2020 Apr 30;382(18):1739-1748. doi: 10.1056/NEJMra1810769. No abstract available.
- Deniau B, Sabze A, Corte H, Cattan P, Walter T, Depret F, Plaud B. Early- and long-term outcomes of patients admitted to intensive care unit for severe caustic ingestion: a 10-year, retrospective, and cohort study. J Gastrointest Surg. 2024 Dec;28(12):2118-2120. doi: 10.1016/j.gassur.2024.09.016. Epub 2024 Sep 18. No abstract available.
- Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Balk EM, Gordon CE, Earley A, Rofeberg V, Knoll GA. Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020 Apr;104(4):708-714. doi: 10.1097/TP.0000000000003137.
- Chirica M, Kelly MD, Siboni S, Aiolfi A, Riva CG, Asti E, Ferrari D, Leppaniemi A, Ten Broek RPG, Brichon PY, Kluger Y, Fraga GP, Frey G, Andreollo NA, Coccolini F, Frattini C, Moore EE, Chiara O, Di Saverio S, Sartelli M, Weber D, Ansaloni L, Biffl W, Corte H, Wani I, Baiocchi G, Cattan P, Catena F, Bonavina L. Esophageal emergencies: WSES guidelines. World J Emerg Surg. 2019 May 31;14:26. doi: 10.1186/s13017-019-0245-2. eCollection 2019.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- DATACAUSTIC /
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .